Fidelity Investments’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Fidelity Investments’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-4,667,500	Closed	-$79.1M	–	2879
2014 Q4	$79.1M	Sell	4,667,500 -15,580,071	-77%	-$219M	0.01%	1123
2014 Q3	$241M	Buy	20,247,571 +6,942,771	+52%	+$47.4M	0.03%	566
2014 Q2	$75M	Buy	13,304,800 +1,106,600	+9%	+$5.1M	0.01%	1155
2014 Q1	$44.8M	Buy	12,198,200 +3,363,300	+38%	+$12.8M	0.01%	1383
2013 Q4	$29.7M	Sell	8,834,900 -3,180,956	-26%	-$13.1M	﹤0.01%	1555
2013 Q3	$50.9M	Sell	12,015,856 -701,017	-6%	-$3.32M	0.01%	1273
2013 Q2	$58.5M	Buy	+12,716,873	New	+$43.7M	0.01%	1177

Fidelity Investments's AVNR Position: Q1 2015 in Review

Fidelity Investments sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 4,667,500 shares — an estimated $79.1M sold.

Fidelity Investments first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $241M in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Fidelity Investments reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Fidelity Investments sold 4,667,500 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $79.1M.
Fidelity Investments first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
Fidelity Investments's AVANIR PHARMACEUTICALS, INC CL A position peaked at $241M in Q3 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Fidelity Investments's 13F filing for Q1 2015, filed 14 May 2015.